Thursday’s Midday Movers: Aeterna Zentaris (AEZS), Anthera Pharmaceuticals (ANTH), Fuelcell Energy (FCEL), Medical Marijuana Inc (MJNA), Noble Corp (NE)

By Carrie Williams

So far Thursday, June 13, NASDAQ is up 0.15% and the S&P is up 0.16%. Here are this morning’s most active stocks: Aeterna Zentaris (AEZSResearch Report), Anthera Pharmaceuticals (ANTHResearch Report), Fuelcell Energy (FCELResearch Report), Medical Marijuana Inc (MJNAResearch Report) and Noble Corp (NEResearch Report).

Aeterna Zentaris is up 20.69% in midday trading to $2.80. Shares opened today at $2.32. The company has a 52-week low of $1.29 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $5.50, marking a 137.07% potential upside from current levels. In a report issued on May 21, H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on AEZS, with a price target of $5.50, which implies an upside of 137% from current levels.

Anthera Pharmaceuticals is up 16.18% in midday trading to $0.06. Shares opened today at $0.06. The company has a 52-week low of $0.01 and a 52-week high of $0.00.

Fuelcell Energy is down -14.89% in midday trading to $0.40. Shares opened today at $0.47. The company has a 52-week low of $0.20 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.00, marking a 112.77% potential upside from current levels. In a report issued on June 6, Oppenheimer analyst Colin Rusch downgraded FCEL to Hold.

See today’s analyst top recommended stocks >>

Medical Marijuana Inc is down -13.48% in midday trading to $0.06. Shares opened today at $0.06. The company has a 52-week low of $0.04 and a 52-week high of $0.00.

See today’s analyst top recommended stocks >>

Noble Corp is down -10.22% in midday trading to $1.67. Shares opened today at $1.86. The company has a 52-week low of $1.62 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.38, marking a -25.81% potential downside from current levels. In a report issued on June 10, Merrill Lynch analyst Chase Mulvehill resumed coverage with a Sell rating on NE and a price target of $1.25, which implies a downside of 33% from current levels.

Trending Stocks Based on Insider Activity >>